Michael A. Beeuwsaert
Plus aucun poste en cours
Profil
Michael A.
Beeuwsaert is the founder of Numira, Inc. Prior to founding Numira, he served as President & CEO of LXN Corp from 1999 to 2001, President & CEO of Alerion Biomedical, Inc. from 2002 to 2005, and Vice President-Finance at ANSYS Diagnostics, Inc. He received an undergraduate degree from California State University-Chico and an MBA from Pepperdine University.
Anciens postes connus de Michael A. Beeuwsaert
| Sociétés | Poste | Fin |
|---|---|---|
Alerion Biomedical, Inc.
 Alerion Biomedical, Inc. Medical SpecialtiesHealth Technology Alerion Biomedical, Inc. manufactures novel technologies for improving detection. It also manufactures biomarkers and contrast media for preclinical and clinical imaging devices. The company is headquartered in San Diego, CA. | President | 01/11/2005 |
LXN Corp
 LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | President | 01/04/2001 |
| ANSYS Diagnostics, Inc. | Directeur Financier/CFO | - |
Numira, Inc.
 Numira, Inc. Medical/Nursing ServicesHealth Services Numira, Inc. develops and provides molecular imaging technologies for scientific discovery and drug development. Its products include AltaBlu Prime, AltaNexus and AltaViewer. The firm operates as a contract research organization, which provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. The company services include 3D oncology cell screening, histology, image analysis and imaging. Its therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation provide extensive value for many researchers. Through the combination of novel software technologies and imaging capabilities, Numira provides clients with an unmatched array of pre-clinical services for research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other therapeutic areas. Numira was founded in 2005 by Michael A. Beeuwsaert and Charles Keller and is headquartered in Salt Lake, UT. | Fondateur | - |
Formation de Michael A. Beeuwsaert
| California State University-Chico | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| ANSYS Diagnostics, Inc. | Health Technology |
LXN Corp
LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Health Technology |
Alerion Biomedical, Inc.
Alerion Biomedical, Inc. Medical SpecialtiesHealth Technology Alerion Biomedical, Inc. manufactures novel technologies for improving detection. It also manufactures biomarkers and contrast media for preclinical and clinical imaging devices. The company is headquartered in San Diego, CA. | Health Technology |
Numira, Inc.
Numira, Inc. Medical/Nursing ServicesHealth Services Numira, Inc. develops and provides molecular imaging technologies for scientific discovery and drug development. Its products include AltaBlu Prime, AltaNexus and AltaViewer. The firm operates as a contract research organization, which provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. The company services include 3D oncology cell screening, histology, image analysis and imaging. Its therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation provide extensive value for many researchers. Through the combination of novel software technologies and imaging capabilities, Numira provides clients with an unmatched array of pre-clinical services for research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other therapeutic areas. Numira was founded in 2005 by Michael A. Beeuwsaert and Charles Keller and is headquartered in Salt Lake, UT. | Health Services |
